AFLIBERCEPT IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC): FINAL RESULTS OF A MULTINATIONAL PLACEBO-CONTROLLED PHASE III TRIAL (EFC10261-VITAL)

Date
2011
Author
Bennouna, Jaafar
Ozguroglu, Mustafa
Baldotto, Clarissa
Shepherd, Frances A.
Scagliotti, Giorgio
Novello, Silvia
Ramlau, Rodryg
Gorbunova, Vera A.
Ciuleanu, Tudor E.
GÖKSEL, TUNCAY
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/121232
Collections